Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide
Clinical trial NCT03764540 · TERMINATED
Trial details
- NCT number
- NCT03764540
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2024-12-31
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.